Navendu D. Samant, Ph.D.

2010 Pharmaceutical Health Services Research University of Maryland School of Medicine, Baltimore, MD, United States 
Pharmacy, Public Health, Health Care Management
"Navendu Samant"
Cross-listing: PHTree


Sign in to add mentor
Fadia T. Shaya grad student 2010 University of Maryland Medical School
 (Clinical and economic impact of statin therapy compliance on hyperlipidemic patients with concomitant CHD risk factors.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shaya FT, Samant N, Pradel F, et al. (2007) Health-related quality of life as a potential predictor in chronic obstructive lung disease patients. Expert Review of Pharmacoeconomics & Outcomes Research. 7: 129-35
Shaya F, Samant N, Saunders E. (2007) Pdb23 Impact Of Patient Education On Hba1C Reduction In Diabetic Patients With Concomitant Hypertension Value in Health. 10
Samant N, Shaya F, Khoury AE. (2006) Pcv61 Determinants Of Adherence To Statins Ina Medicaid Managed Care Population Value in Health. 9
Khoury AE, Shaya F, Samant N. (2006) Pcv60 Impact Of Adherence To Antihyperlipidemic Drugs On Total Pharmacy And Medical Costs Value in Health. 9
Shaya F, Samant N, Khoury AE. (2006) Pcv9 Cardiovascular Risk Predicted By Adherence To Statins In A Medicaid Population Value in Health. 9
Shaya FT, El Khoury AC, Samant ND, et al. (2006) Utilization of health care resources in a high-risk medicaid population with chronic obstructive pulmonary disease P and T. 31: 261-268
Shaya FT, Samant N, Skolasky R, et al. (2005) Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores. Expert Review of Pharmacoeconomics & Outcomes Research. 5: 625-32
Shaya FT, Samant N. (2004) Formulary decision methodology in the context of health system costs and insurance trends. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 595-7
Shaya FT, Samant N. (2004) Cost studies in clinical trials. Expert Review of Pharmacoeconomics & Outcomes Research. 4: 591-4
Shaya FT, Wong W, Shin JY, et al. (2004) Formulary decision-making considerations: COX-2 inhibitors. Managed Care Interface. 17: 29-36, 41
See more...